|
1
|
Khand A, Gemmel I, Clark AL and Cleland
JG: Is the prognosis of heart failure improving? J Am Coll Cardiol.
36:2284–2286. 2000. View Article : Google Scholar
|
|
2
|
Cleland JG and Clark AL: Delivering the
cumulative benefits of triple therapy to improve outcomes in heart
failure: too many cooks will spoil the broth. J Am Coll Cardiol.
42:1234–1237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Young JB, Abraham WT, Smith AL, et al:
Combined cardiac resynchronization and implantable cardioversion
defibrillation in advanced chronic heart failure: the MIRACLE ICD
Trial. JAMA. 289:2685–2694. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abraham WT, Fisher WG, Smith AL, et al:
Cardiac resynchronization in chronic heart failure. N Engl J Med.
346:1845–1853. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Higgins SL, Hummel JD, Niazi IK, et al:
Cardiac resynchronization therapy for the treatment of heart
failure in patients with intraventricular conduction delay and
malignant ventricular tachyarrhythmias. J Am Coll Cardiol.
42:1454–1459. 2003. View Article : Google Scholar
|
|
6
|
Bristow MR, Saxon LA, Boehmer J, et al:
Cardiac-resynchronization therapy with or without an implantable
defibrillator in advanced chronic heart failure. N Engl J Med.
350:2140–2150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Auricchio A, Stellbrink C, Sack S, et al:
Long-term clinical effect of hemodynamically optimized cardiac
resynchronization therapy in patients with heart failure and
ventricular conduction delay. J Am Coll Cardiol. 39:2026–2033.
2002. View Article : Google Scholar
|
|
8
|
Thomas DE, Yousef ZR and Fraser AG: A
critical comparison of echocardiographic measurements used for
optimizing cardiac resynchronization therapy: stroke distance is
best. Eur J Heart Fail. 11:779–788. 2009. View Article : Google Scholar
|
|
9
|
Bhan A, Kapetanakis S and Monaghan MJ:
Optimization of cardiac resynchronization therapy.
Echocardiography. 25:1031–1039. 2008. View Article : Google Scholar
|
|
10
|
Stanton T, Hawkins NM, Hogg KJ, Goodfield
NE, Petrie MC and McMurray JJ: How should we optimize cardiac
resynchronization therapy? Eur Heart J. 29:2458–2472. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ypenburg C, Van De Veire N, Westenberg JJ,
et al: Noninvasive imaging in cardiac resynchronization therapy -
Part 2: Follow-up and optimization of settings. Pacing Clin
Electrophysiol. 31:1628–1639. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung ES, Leon AR, Tavazzi L, et al:
Results of the Predictors of Response to CRT (PROSPECT) trial.
Circulation. 117:2608–2616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bax JJ and Gorcsan J III: Echocardiography
and noninvasive imaging in cardiac resynchronization therapy:
results of the PROSPECT (Predictors of Response to Cardiac
Resynchronization Therapy) study in perspective. J Am Coll Cardiol.
53:1933–1943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Achilli A, Peraldo C, Sassara M, et al:
Prediction of response to cardiac resynchronization therapy: the
selection of candidates for CRT (SCART) study. Pacing Clin
Electrophysiol. 29:11–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz-Infante E, Mont L, Leal J, et al:
Predictors of lack of response to resynchronization therapy. Am J
Cardiol. 95:1436–1440. 2005.
|
|
16
|
Cleland JG, Daubert JC, Erdmann E, et al:
The CARE-HF study (Cardiac Resynchronisation in Heart Failure
study): rationale, design and end-points. Eur J Heart Fail.
3:481–489. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calvert MJ, Freemantle N and Cleland JG:
The impact of chronic heart failure on health-related quality of
life data acquired in the baseline phase of the CARE-HF study. Eur
J Heart Fail. 7:243–251. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cleland JG, Daubert JC, Erdmann E, et al:
Baseline characteristics of patients recruited into the CARE-HF
study. Eur J Heart Fail. 7:205–214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rector TS, Kubo SH and Cohn JN: Validity
of the Minnesota Living with Heart Failure questionnaire as a
measure of therapeutic response to enalapril or placebo. Am J
Cardiol. 71:1106–1107. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mollema SA, Bleeker GB, van der Wall EE,
Schalij MJ and Bax JJ: Usefulness of QRS duration to predict
response to cardiac resynchronization therapy in patients with
end-stage heart failure. Am J Cardiol. 100:1665–1670. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duncan AM, Lim E, Clague J and Henein MY:
Comparison of segmental and global markers of dyssynchrony in
predicting clinical response to cardiac resynchronization. Eur
Heart J. 27:2426–2432. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu CM, Bleeker GB, Fung JW, et al: Left
ventricular reverse remodeling but not clinical improvement
predicts long-term survival after cardiac resynchronization
therapy. Circulation. 112:1580–1586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shewan LG and Coats AJ: Ethics in the
authorship and publishing of scientific articles. Int J Cardiol.
144:1–2. 2010. View Article : Google Scholar
|
|
24
|
Daubert JC, Ritter P, Le Breton H, et al:
Permanent left ventricular pacing with transvenous leads inserted
into the coronary veins. Pacing Clin Electrophysiol. 21:239–245.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schiller NB, Shah PM, Crawford M, et al:
Recommendations for quantitation of the left ventricle by
two-dimensional echocardiography. American Society of
Echocardiography Committee on Standards, Subcommittee on
Quantitation of Two-Dimensional Echocardiograms. J Am Soc
Echocardiogr. 2:358–367. 1989. View Article : Google Scholar
|
|
26
|
Zoghbi WA, Enriquez-Sarano M, Foster E, et
al: Recommendations for evaluation of the severity of native
valvular regurgitation with two-dimensional and Doppler
echocardiography. J Am Soc Echocardiogr. 16:777–802. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baldasseroni S, Opasich C, Gorini M, et
al: Left bundle-branch block is associated with increased 1-year
sudden and total mortality rate in 5517 outpatients with congestive
heart failure: a report from the Italian Network on congestive
heart failure. Am Heart J. 143:398–405. 2002.PubMed/NCBI
|
|
28
|
Cleland JG, Daubert JC, Erdmann E, et al:
The effect of cardiac resynchronization on morbidity and mortality
in heart failure. N Engl J Med. 352:1539–1549. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McAlister FA, Ezekowitz J, Hooton N, et
al: Cardiac resynchronization therapy for patients with left
ventricular systolic dysfunction: a systematic review. JAMA.
2297:2502–2514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Bommel RJ, Borleffs CJ, Ypenburg C, et
al: Morbidity and mortality in heart failure patients treated with
cardiac resynchronization therapy: influence of pre-implantation
characteristics on long-term outcome. Eur Heart J. 31:2783–2790.
2010.PubMed/NCBI
|
|
31
|
Vanderheyden M, De Backer T, Rivero-Ayerza
M, et al: Tailored echocardiographic interventricular delay
programming further optimizes left ventricular performance after
cardiac resynchronization therapy. Heart Rhythm. 2:1066–1072. 2005.
View Article : Google Scholar
|
